Pfizer will dominate $28 billion COVID-pill market in 2022With the rapid spread of Omicron across the globe and the strong reluctance from Governments to shut down again, it will be interesting to see how quickly a Covid tablet will become available on mass.
Pfizer is tipped by a few different sources to be the likely one to take the lead.
Share price looks too hot at the moment so will keep an eye on it for a pullback.
Strong run at the moment.